Nippon Shinyaku Co. Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the First Half of Fiscal 2018 and Full Year Ending March 31, 2019
May 09, 2018
Share
Nippon Shinyaku Co. Ltd. reported consolidated earnings results for the year ended March 31, 2018. For the year, the company's net sales were ¥101,448 million against ¥98,781 million a year ago. Operating income was ¥17,079 million against ¥15,280 million a year ago. Ordinary income was ¥17,451 million against ¥16,244 million a year ago. Net income attributable to owners of the parent was ¥12,953 million against ¥11,749 million a year ago. Net income per share basic was ¥192.31 compared to ¥174.42 a year ago. Return in equity was 10.8% against 10.8% a year ago. Income before income taxes and minority interests was ¥17,451 million compared to ¥15,477 million a year ago. Net cash provided by operating activities was ¥6,719 million compared to ¥18,916 million a year ago. Purchases of tangible fixed assets were ¥4,017 million compared to ¥4,131 million a year ago. Purchases of intangible assets were ¥160 million compared to ¥221 million a year ago.
The company provided earnings guidance for the first half of fiscal 2018 and full year ending March 31, 2019. For the first half of fiscal 2018, the company expects net sales to be ¥52,000 million, operating income to be ¥6,500 million, ordinary income to be ¥6,800 million, net income attributable to owners of the parent to be ¥4,900 million or ¥72.75 per share.
For the year ending March 31, 2019, the company expects net sales to be ¥108,000 million, Operating income to be ¥18,500 million, ordinary income to be ¥19,000 million, net income attributable to owners of the parent to be ¥14,000 million or ¥207.85 per share.
Nippon Shinyaku Co., Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceutical products and functional foodstuffs. The Company operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The Company is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
Nippon Shinyaku Co. Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the First Half of Fiscal 2018 and Full Year Ending March 31, 2019